Benjámin Bereznai

1.7k total citations
28 papers, 1.2k citations indexed

About

Benjámin Bereznai is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Benjámin Bereznai has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 14 papers in Cellular and Molecular Neuroscience and 8 papers in Molecular Biology. Recurrent topics in Benjámin Bereznai's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Genetic Neurodegenerative Diseases (7 papers) and Neurological disorders and treatments (6 papers). Benjámin Bereznai is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Genetic Neurodegenerative Diseases (7 papers) and Neurological disorders and treatments (6 papers). Benjámin Bereznai collaborates with scholars based in Hungary, Germany and United States. Benjámin Bereznai's co-authors include Thomas Gasser, Vincenzo Bonifati, Edito Fabrizio, Bertram Müller‐Myhsok, Rolf D. Horstmann, Ralph Oehlmann, Donald B. Calne, P. Vieregge, Zbigniew K. Wszołek and Kai Bötzel and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Benjámin Bereznai

27 papers receiving 1.2k citations

Peers

Benjámin Bereznai
Benjámin Bereznai
Citations per year, relative to Benjámin Bereznai Benjámin Bereznai (= 1×) peers Kotaro Ogaki

Countries citing papers authored by Benjámin Bereznai

Since Specialization
Citations

This map shows the geographic impact of Benjámin Bereznai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjámin Bereznai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjámin Bereznai more than expected).

Fields of papers citing papers by Benjámin Bereznai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjámin Bereznai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjámin Bereznai. The network helps show where Benjámin Bereznai may publish in the future.

Co-authorship network of co-authors of Benjámin Bereznai

This figure shows the co-authorship network connecting the top 25 collaborators of Benjámin Bereznai. A scholar is included among the top collaborators of Benjámin Bereznai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjámin Bereznai. Benjámin Bereznai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varga, Edina, Zoltán Grosz, Benjámin Bereznai, et al.. (2016). Three novel mutations and genetic epidemiology analysis of the Gap Junction Beta 1 (GJB1) gene among Hungarian Charcot-Marie-Tooth disease patients. Neuromuscular Disorders. 26(10). 706–711. 6 indexed citations
2.
Böhm, Josef, et al.. (2014). Different Patterns of Nerve Enlargement in Polyneuropathy Subtypes as Detected by Ultrasonography. Ultrasound in Medicine & Biology. 40(6). 1138–1145. 39 indexed citations
3.
Trampush, Joey W., et al.. (2014). Mitochondrial DNA Mutations and Cognition: A Case-Series Report. Archives of Clinical Neuropsychology. 29(4). 315–321. 30 indexed citations
4.
Schulte, Eva C., Darina Czamara, Daniel C. Ellwanger, et al.. (2013). Rare Variants in PLXNA4 and Parkinson’s Disease. PLoS ONE. 8(11). e79145–e79145. 15 indexed citations
5.
Bereznai, Benjámin, Annamária Takáts, Péter Klivènyi, et al.. (2012). [The absence of the common LRRK2 G2019S mutation in 120 young onset Hungarian Parkinon's disease patients].. PubMed. 65(7-8). 239–42. 2 indexed citations
6.
Gál, Anikó, et al.. (2012). Psychiatric symptoms of patients with primary mitochondrial DNA disorders. Behavioral and Brain Functions. 8(1). 9–9. 43 indexed citations
7.
Schulte, Eva C., Brit Mollenhauer, Alexander Zimprich, et al.. (2012). Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson’s disease. Neurogenetics. 13(3). 281–285. 25 indexed citations
8.
Böhm, Josef, Magdolna Simó, Csilla Rózsa, et al.. (2012). Ultrasonography of MADSAM neuropathy: Focal nerve enlargements at sites of existing and resolved conduction blocks. Neuromuscular Disorders. 22(7). 627–631. 65 indexed citations
9.
Bereznai, Benjámin, et al.. (2010). Coexisting huntingtin and SCA8 repeat expansion: Case report of a severe complex neurodegenerative syndrome. Journal of the Neurological Sciences. 293(1-2). 116–118. 2 indexed citations
10.
Bereznai, Benjámin & Mária Judit Molnár. (2009). [Genetics and present therapy options in Parkinson's disease: a review].. PubMed. 62(5-6). 155–63. 3 indexed citations
11.
Bereznai, Benjámin, Norbert Goebels, Tommy Dang, et al.. (2008). Therapie der multiplen Sklerose. DMW - Deutsche Medizinische Wochenschrift. 124(19). 595–599. 1 indexed citations
13.
Harhangi, Biswadjiet S., Matthew J. Farrer, Sarah Lincoln, et al.. (1999). The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease. Neuroscience Letters. 270(1). 1–4. 57 indexed citations
14.
Gasser, Thomas, Klaus Windgassen, Benjámin Bereznai, Christian Kabus, & Albert C. Ludolph. (1998). Phenotypic expression of the DYT1 mutation: A family with writer's cramp of juvenile onset. Annals of Neurology. 44(1). 126–128. 101 indexed citations
15.
Gasser, Thomas, Bertram Müller‐Myhsok, Zbigniew K. Wszołek, et al.. (1998). A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nature Genetics. 18(3). 262–265. 350 indexed citations
16.
Vaughan, Jenny, Alexandra Dürr, Jean‐Pol Tassin, et al.. (1998). The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases. Annals of Neurology. 44(2). 270–273. 67 indexed citations
17.
Bereznai, Benjámin, Andrea Sylvia Winkler, Gian Domenico Borasio, & Thomas Gasser. (1997). A novel SOD1 mutation in an Austrian family with amyotrophic lateral sclerosis. Neuromuscular Disorders. 7(2). 113–116. 13 indexed citations
18.
Gasser, Thomas, et al.. (1996). Linkage studies in alcohol‐responsive myoclonic dystonia. Movement Disorders. 11(4). 363–370. 19 indexed citations
19.
20.
Deckert, Jürgen, et al.. (1993). Nimodipine inhibits [3H]nitrobenzylthioinosine binding to the adenosine transporter in human brain. European Journal of Pharmacology. 238(1). 131–133. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026